First drug-eluting contact lens approved in Japan

April 15, 2021
Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

,
Brian Pall, OD, MS, FAAO

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses. This lens was recently approved in Japan for vision correction and allergy symptom relief. Brian Pall, OD, MS, FAAO, director of clinical science at Johnson & Johnson Vision Care, discusses the lens and its technology.